Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 50

recruiting
3 983
countries
28
conditions
2 109

10 385 trials match your criteria

Adenomyosis

Recruiting

A study to evaluate the effect of valproic acid in women of reproductive age with adenomyosis

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Ibuprofen

Study of ASP-1929 and pembrolizumab for patients with recurrent head and neck squamous cell carcinoma without distant metastases

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years

A study to evaluate the safety and effectiveness of ANXV in patients with diabetic retinopathy or retinal vein occlusion

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years

A study of tirzepatide and levonorgestrel in women with endometrial cancer

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Levonorgestrel
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Colesevelam hydrochloride

Obesity+2

Recruiting

Study of the efficacy and safety of Eloralintide in adults with knee osteoarthritis and overweight or obesity

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:LY3841136 sodium

A study to evaluate the safety and effectiveness of surlorian in adults with RYR1-related myopathy

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years

A study to evaluate the use of levothyroxine sodium in patients with sudden onset of dizziness caused by inner ear issues.

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years

Study of pembrolizumab, capecitabine, or olaparib in patients with early-stage triple negative breast cancer and remaining disease after initial treatment

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years

A study to evaluate the safety and effectiveness of filgotinib in children and adolescents with juvenile idiopathic arthritis.

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years

Psoriasis

Recruiting

A study to evaluate the effectiveness and safety of zasocitinib in children and adolescents with moderate-to-severe plaque psoriasis

Investigational
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Zasocitinib

Hidradenitis

Recruiting

A study to evaluate the effectiveness and safety of LAD328 in adults with moderate to severe hidradenitis suppurativa

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.